Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

NCT01098474 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: GSK's investigational vaccine 692342
BIOLOGICAL: Tritanrix™ HB+Hib
BIOLOGICAL: Prevnar™
BIOLOGICAL: Polio Sabin™
BIOLOGICAL: Menjugate™

Sponsor

GlaxoSmithKline

Collaborators

[object Object]